| 000 | 01861 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515010019.0 | ||
| 264 | 0 | _c20051213 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a0003-9926 | ||
| 024 | 7 |
_a10.1001/archinte.165.21.2479 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBallantyne, Christie M | |
| 245 | 0 | 0 |
_aLipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. _h[electronic resource] |
| 260 |
_bArchives of internal medicine _cNov 2005 |
||
| 300 |
_a2479-84 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a1-Alkyl-2-acetylglycerophosphocholine Esterase |
| 650 | 0 | 4 |
_aAtherosclerosis _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBrain Ischemia _xblood |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoassay |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPhospholipases A _xblood |
| 650 | 0 | 4 | _aPhospholipases A2 |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aHoogeveen, Ron C | |
| 700 | 1 | _aBang, Heejung | |
| 700 | 1 | _aCoresh, Josef | |
| 700 | 1 | _aFolsom, Aaron R | |
| 700 | 1 | _aChambless, Lloyd E | |
| 700 | 1 | _aMyerson, Merle | |
| 700 | 1 | _aWu, Kenneth K | |
| 700 | 1 | _aSharrett, A Richey | |
| 700 | 1 | _aBoerwinkle, Eric | |
| 773 | 0 |
_tArchives of internal medicine _gvol. 165 _gno. 21 _gp. 2479-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archinte.165.21.2479 _zAvailable from publisher's website |
| 999 |
_c15937264 _d15937264 |
||